We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Rectangle Image
Webinar

Development and Validation of a Duplex qPCR Assay for the Detection of Residual Sf9 Host Cell DNA and Baculovirus DNA

Rectangle Image
Webinar

Development and Validation of a Duplex qPCR Assay for the Detection of Residual Sf9 Host Cell DNA and Baculovirus DNA

Dr Kara Norman
Dr Kara Norman
Senior Manager, Research and Development, Pharmaceutical Analytics, Thermo Fisher Scientific
Mike Auerbach
Mike Auerbach
Moderator, Editor-in-Chief, American Pharmaceutical Review

Current regulatory authorities (WHO, EMA and US FDA) limited the accepted amounts of residual DNA in biological products making it extremely important to have a sensitive method of quantifying residual host cell DNA. Among the methods of detecting residual DNA, qPCR is the most widely used for residual DNA quantitation due to its sensitivity, accuracy, precision, and time-saving capability.

In this webinar, we share the development and validation of a new, highly sensitive and accurate integrated solution for detection and quantitation of low level Sf9 and Baculovirus DNA to help meet regulatory requirements.

Watch now to learn about:

  • Summary of current regulatory requirements for residual host DNA clearance for biological products and what that means for gene therapy applications
  • Demonstration of a streamlined, automated workflow for quick quantification of residual Sf9 host cell DNA and helper baculovirus DNA
  • Performance specifications for the new Applied Biosystems resDNASEQ Quantitative Sf9 and Baculovirus DNA system
Advertisement